Long-term Study to Evaluate Safety and Tolerability of Valbenazine in Participants With Chorea Associated With Huntington Disease in Canada
Clinical trial NCT06312189 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06312189
- Sponsor
- Neurocrine Biosciences
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-24
- Primary completion
- 2028-04-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.